0
Antipsychotic Dosing: Still a Work in Progress
Gary Remington, M.D., Ph.D., F.R.C.P.C.
Issues for DSM-5: Conversion Disorder
Jon Stone, M.B., Ch.B, M.R.C.P., Ph.D.; W. Curt LaFrance, Jr., M.D., M.P.H.; James L. Levenson, M.D.; Michael Sharpe, M.D.
Emotion Modulation in PTSD: Clinical and Neurobiological Evidence for a Dissociative Subtype
Ruth A. Lanius, M.D., Ph.D.; Eric Vermetten, M.D., Ph.D.; Richard J. Loewenstein, M.D.; Bethany Brand, Ph.D.; Christian Schmahl, M.D.; J. Douglas Bremner, M.D.; David Spiegel, M.D.
Time to Attainment of Recovery From Borderline Personality Disorder and Stability of Recovery: A 10-year Prospective Follow-Up Study
Mary C. Zanarini, Ed.D.; Frances R. Frankenburg, M.D.; D. Bradford Reich, M.D.; Garrett Fitzmaurice, Sc.D.
A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol Dependence
Helen M. Pettinati, Ph.D.; David W. Oslin, M.D.; Kyle M. Kampman, M.D.; William D. Dundon, Ph.D.; Hu Xie, M.S.; Thea L. Gallis, B.A.; Charles A. Dackis, M.D.; Charles P. O'Brien, M.D., Ph.D.
Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial
Chuan-Yue Wang, M.D., Ph.D.; Yu-Tao Xiang, M.D., Ph.D.; Zhuo-Ji Cai, M.D.; Yong-Zhen Weng, M.D.; Qi-Jing Bo, M.D.; Jing-Ping Zhao, M.D., Ph.D.; Tie-Qiao Liu, M.D., Ph.D.; Gao-Hua Wang, M.D., Ph.D.; Shi-Min Weng, M.D.; Hong-Yan Zhang, M.D.; Da-Fang Chen, Ph.D.; Wai-Kwong Tang, M.D.; Gabor S. Ungvari, M.D., Ph.D.;
CME   International Consensus Study of Antipsychotic Dosing
David M. Gardner, Pharm.D., M.Sc.; Andrea L. Murphy, Pharm.D.; Heather O'Donnell, B.Sc. Pharm.; Franca Centorrino, M.D.; Ross J. Baldessarini, M.D.
Life-Threatening Danger and Suppression of Attention Bias to Threat
Yair Bar-Haim, Ph.D.; Yael Holoshitz, B.S.; Sharon Eldar, M.A.; Tahl I. Frenkel, M.A.; David Muller, M.D.; Dennis S. Charney, M.D.; Daniel S. Pine, M.D.; Nathan A. Fox, Ph.D.; Ilan Wald, M.A.
CME   Reward/Punishment Reversal Learning in Older Suicide Attempters
Alexandre Y. Dombrovski, M.D.; Luke Clark, D.Phil.; Greg J. Siegle, Ph.D.; Meryl A. Butters, Ph.D.; Naho Ichikawa, M.S.; Barbara J. Sahakian, Ph.D.; Katalin Szanto, M.D.
Gender and Depressive Symptoms in 711 Patients With Bipolar Disorder Evaluated Prospectively in the Stanley Foundation Bipolar Treatment Outcome Network
Lori L. Altshuler, M.D.; Ralph W. Kupka, M.D.; Gerhard Hellemann, Ph.D.; Mark A. Frye, M.D.; Catherine A. Sugar, Ph.D.; Susan L. McElroy, M.D.; Willem A. Nolen, M.D.; Heinz Grunze, M.D., Ph.D.; Gabriele S. Leverich, M.S.W.; Paul E. Keck, Jr., M.D.; Melanie Zermeno, M.D.; Robert M. Post, M.D.; Trisha Suppes, M.D., Ph.D.
Resolving the Discrepancy in Childhood Bipolar High-Risk Study Findings
Anne Duffy, M.D., F.R.C.P.C.; Paul Grof, M.D., Ph.D., F.R.C.P.C.; Tomas Hajek, M.D., Ph.D.; Martin Alda, M.D., F.R.C.P.C.
Drs. Birmaher, Axelson, Tina Goldstein, and Benjamin Goldstein Reply
Boris Birmaher, M.D.; David Axelson, M.D.; Tina Goldstein, Ph.D.; Benjamin Goldstein, M.D.
Schizophrenia and Childhood Adversity
John Read, Ph.D.; Richard Bentall, Ph.D.
Drs. Christian Kieling, Renata Kieling, and Rohde Reply
Christian Kieling, M.D.; Renata R. Kieling, M.D.; Luis Augusto Rohde, M.D., Ph.D.
Dr. Gilmore Replies
John H. Gilmore, M.D.
Dr. Kéri Replies
Szabolcs Kéri, M.D., Ph.D., D.Sc.
Varenicline Withdrawal-Induced Delirium With Psychosis
Alison C. May, M.D.; Demian Rose, M.D., Ph.D.